Skip to main content

Rigel Pharmaceuticals Inc

RIGL
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001034842

No open-market purchases or sales by Rigel Pharmaceuticals Inc insiders were filed in the last 90 days; 155 institutions reported holding it in 13F filings for Q2 2026, worth $640.4M in total; no superinvestor holds it.

13F holders, Q1 2023

Institutional positions in Rigel Pharmaceuticals Inc as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
125
+8 vs. Q4 2022
Shares held
112.4M
+4.03M (+3.7%) vs. Q4 2022
Total value
$148.6M
−$14.0M (−8.6%) vs. Q4 2022
New holders
19
35 more added
Sold out
11
37 more reduced

1 institution that held it in Q4 2022 haven't filed for Q1 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q4 2022: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting RIGL on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2023: 125 institutions
Q1 2021: 152 institutionsQ2 2021: 160 institutionsQ3 2021: 163 institutionsQ4 2021: 162 institutionsQ1 2022: 163 institutionsQ2 2022: 135 institutionsQ3 2022: 138 institutionsQ4 2022: 118 institutionsQ1 2023: 125 institutionsQ2 2023: 118 institutionsQ3 2023: 106 institutionsQ4 2023: 113 institutionsQ1 2024: 117 institutionsQ2 2024: 91 institutionsQ3 2024: 93 institutionsQ4 2024: 122 institutionsQ1 2025: 123 institutionsQ2 2025: 126 institutionsQ3 2025: 169 institutionsQ4 2025: 194 institutionsQ1 2026: 159 institutionsQ2 2026: 155 institutions
Value heldQ1 2023: $148.6M
Q1 2021: $493.1MQ2 2021: $614.5MQ3 2021: $499.6MQ4 2021: $365.9MQ1 2022: $405.7MQ2 2022: $157.2MQ3 2022: $150.3MQ4 2022: $163.1MQ1 2023: $148.6MQ2 2023: $142.7MQ3 2023: $114.8MQ4 2023: $154.5MQ1 2024: $164.3MQ2 2024: $85.4MQ3 2024: $192.6MQ4 2024: $203.0MQ1 2025: $250.2MQ2 2025: $260.2MQ3 2025: $425.6MQ4 2025: $690.5MQ1 2026: $432.8MQ2 2026: $640.4M
Institutions holding RIGL and their total value by quarter
QuarterHoldersValue
Q2 2026155$640.4M
Q1 2026159$432.8M
Q4 2025194$690.5M
Q3 2025169$425.6M
Q2 2025126$260.2M
Q1 2025123$250.2M
Q4 2024122$203.0M
Q3 202493$192.6M
Q2 202491$85.4M
Q1 2024117$164.3M
Q4 2023113$154.5M
Q3 2023106$114.8M
Q2 2023118$142.7M
Q1 2023125$148.6M
Q4 2022118$163.1M
Q3 2022138$150.3M
Q2 2022135$157.2M
Q1 2022163$405.7M
Q4 2021162$365.9M
Q3 2021163$499.6M
Q2 2021160$614.5M
Q1 2021152$493.1M

Institutions, Q1 2023

Shares, value and share of portfolio for each institution holding Rigel Pharmaceuticals Inc; share changes are against Q4 2022.

Institutions holding RIGL in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
UBS Oconnor LLC757,511$999.9K0.02%+757,511New
Charles Schwab Investment Management Inc866,315$1.14M0.00%+65,618+8.2%Added
Rhenman & Partners Asset Management AB1,157,593$1.55M0.17%−67,488−5.5%Reduced
Assenagon Asset Management S.A.1,307,288$1.73M0.01%+482,430+58.5%Added
Voya Investment Management LLC1,348,232$1.78M0.00%−1,650,259−55.0%Reduced
CM Management, LLC1,500,000$1.98M2.35%00.0%Unchanged
Northern Trust Corp1,519,302$2.01M0.00%+10,096+0.7%Added
Macquarie Group Ltd1,600,000$2.11M0.00%00.0%Unchanged
DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main1,822,376$2.41M0.00%−382,044−17.3%Reduced
Sphera Funds Management Ltd.1,878,845$2.48M0.54%−400,000−17.6%Reduced
Renaissance Technologies LLC1,978,718$2.61M0.00%+1,180,218+147.8%Added
Tamarack Advisers, LP2,000,000$2.64M2.01%−300,000−13.0%Reduced
Two Sigma Investments, LP2,235,049$2.95M0.01%+672,331+43.0%Added
Two Sigma Advisers, LP2,366,691$3.12M0.01%+567,700+31.6%Added
Nuveen Asset Management, LLC2,750,119$3.63M0.00%+33,858+1.2%Added
FMR LLC2,836,324$3.74M0.00%−6,055,683−68.1%Reduced
Geode Capital Management, LLC3,274,591$4.32M0.00%+125,121+4.0%Added
State Street Corp3,446,155$4.55M0.00%+71,241+2.1%Added
Acadian Asset Management LLC3,723,563$4.91M0.02%+182,062+5.1%Added
Jacobs Levy Equity Management, Inc3,773,531$4.98M0.03%−548,941−12.7%Reduced
Millennium Management LLC5,237,117$6.91M0.01%+2,048,839+64.3%Added
Vanguard Group Inc11,359,133$15.0M0.00%−724,663−6.0%Reduced
Soleus Capital Management, L.P.12,803,015$16.9M2.09%+12,803,015New
BlackRock Inc.14,122,161$18.6M0.00%−558,903−3.8%Reduced
Armistice Capital, LLC17,024,000$22.5M0.52%+68,000+0.4%Added
D. E. Shaw & Co., Inc.0$00.00%−3,352,899−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−40,159−100.0%Sold out
Alpine Global Management, LLC0$00.00%−35,840−100.0%Sold out
Balyasny Asset Management LLC0$00.00%−35,534−100.0%Sold out
Diversified Trust Co0$00.00%−31,538−100.0%Sold out
Squarepoint Ops LLC0$00.00%−28,006−100.0%Sold out
American Century Companies Inc0$00.00%−15,501−100.0%Sold out
Group One Trading, L.P.0$00.00%−11,133−100.0%Sold out
Rockefeller Capital Management L.P.0$00.00%−1,052−100.0%Sold out
EWG Elevate Inc.0$00.00%−500−100.0%Sold out
Credit Suisse AG0$00.00%−7−100.0%Sold out
Telemetry Investments, L.L.C.––––Not filed